Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

juan_andres

Moderna appoint Novartis vet to scale-up manufacturing

August 7, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moderna, Novartis, biotech, drugs, pharma, pharmaceutical

Moderna Therapeutics, a clinical stage biotechnology company, has appointed Juan Andres to the position of Senior Vice President of Late …

Appointment
joe_jimenez

Novartis CEO reasserts 2018 growth expectations, discusses Alcon and Sandoz future

July 18, 2017
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, biosimilars, biotech, healthcare, joe jimenez, leukaemia, pharma, pharmaceuticals

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …

News
aedes_aegypti_mosquito

20 million mosquitoes to be released to limit population

July 17, 2017
Research and Development, Sales and Marketing Novartis, Verily, biotech, drugs, google, pharma, pharmaceutical

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

News

Novartis’ breakthrough cancer treatment receives FDA advisory approval

July 13, 2017
Research and Development, Sales and Marketing CAR-T, FDA, Novartis, biotech, drugs, pharma, pharmaceutical

In what could well be a game-changing decision for cancer treatment, the FDA advisory panel gave Novartis’ CAR-T Therapy, CTL019 …

News
ob_logo

Oxford BioMedica in $100 million manufacturing deal with Novartis

July 6, 2017
Manufacturing and Production, Sales and Marketing Novartis, Oxford BioMedica

Oxford BioMedica has announced that it has signed a contract with Novartis to supply the company with materials in a …

News
heart_money

Heart failure market to quadruple in ten years to $16 billion

July 6, 2017
Sales and Marketing GlobalData, Novartis, heart failure

New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …

News
novartis_headquarters

Novartis gains first-line approval for Zykadia in lung cancer

June 29, 2017
Research and Development EMA, European Commission, NSCLC, Novartis

The European Commission has followed the EMA’s CHMP positive opinion by approving Novartis’ Zykadia for first-line treatment of patients with …

News
novartis_side_building

UK launch of two Novartis biosimilars could cut NHS costs

June 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erelzi, Novartis, Rixathon, Sandoz, biosimilar, etanercept, rituximab

Sandoz, a division of Swiss pharma giant Novartis, has revealed that two of its biosimilars – Rixathon (biosimilar rituximab) and …

News
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017
Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …

News
novartis_headquarters

Novartis pulls off surprise success in cardiovascular risk

June 22, 2017
Research and Development, Sales and Marketing Novartis

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

News

Novartis receives positive news in eye drug P3 studies

June 20, 2017
Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron

Novartis has achieved positive feedback from its two Phase 3 studies into its eye drug RTH258 (brolucizumab), which found it …

News
shutterstock_232245868

Severe asthma patients require more support, Novartis study suggests

June 19, 2017
Research and Development, Sales and Marketing Novartis, asthma

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …

News
novartis_window

Novartis receives European biosimilar approval for Roche blockbuster

June 19, 2017
Sales and Marketing Novartis, Rituxan, Rixathon, Roche

Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …

News

Novartis’ Cosentyx shines in ankylosing spondylitis and psoriatic arthritis

June 15, 2017
Research and Development Cosentyx, Novartis

Novartis has released new data on the efficacy of its drug Cosentyx (secukinumab) in the treatment of life-long inflammatory diseases …

News

Continuous Manufacturing: Novartis’ experiment in the future of drug production

June 9, 2017
Manufacturing and Production, Medical Communications Novartis, continuous manufacturing

Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026